SENS News and Press, Senseonics Holdings Inc. From 09/27/22

Finding The Best Penny Stocks To Buy Thanks to a rebound in the stock market today, the hunt for the next round of multi-bagger penny stocks to buy is heating up. In this article, we look at a few stocks under $5 that have experienced higher levels of trading activity. Members of Reddit...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Morgan Stanley ...

The shares of Senseonics Holdings, Inc. ( NYSE: SENS ) dropped ~2% in the afterhours Thursday after the MedTech company announced that its Chief Financial Officer Nick Tressler will leave his position effective Sep. 01. Mr. Tressler will be replaced by Rick Sullivan wh...

Senseonics ( NYSE: SENS ) announced its CFO , Nick Tressler, is transitioning from his position, effective September 1, 2022. Rick Sullivan, Senseonics' current VP of Finance, has been appointed to succeed Mr. Tressler as CFO. Mr. Tressler will...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced its Chief Financial Officer, Nick Tressler, is trans...

Summary The partnership between Senseonics Holdings and Elevance Health (formerly Anthem) is expected to increase coverage to Senseonics' implantable CGM systems including Eversense. Senseonics plans to introduce new diabetes management systems as well as doctors and patients to t...

Senseonics Holdings, Inc. (SENS) Q2 2022 Earnings Conference Call August 9, 2022 16:30 ET Company Participants Philip Taylor - Investor Relations Tim Goodnow - President and Chief Executive Officer Nick Tressler - Financial Officer Mukul Jain - Chief Operatin...

Shares of Senseonics ( NYSE: SENS ) gained 5.4% to $1.96 in Tuesday postmarket trading, after the company reported Q2 results that beat estimates and kept it FY 2022 revenue guidance unchanged. Germantown, Md.-based SENS is medical device company catering to diabetics....

Senseonics press release ( NYSE: SENS ): Q2 GAAP EPS of $0.22 beats by $0.26 . Revenue of $3.7M (+12.1% Y/Y) beats by $0.12M . The company reiterates the expectation for full year 2022 global net revenue to be in the range of $14M to $18M vs. consensus of $16.8...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended June 30, 2022...